• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃博拉病毒糖蛋白在病毒发病机制中的作用。

The roles of ebolavirus glycoproteins in viral pathogenesis.

机构信息

State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.

出版信息

Virol Sin. 2017 Feb;32(1):3-15. doi: 10.1007/s12250-016-3850-1. Epub 2016 Nov 14.

DOI:10.1007/s12250-016-3850-1
PMID:27853993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6791933/
Abstract

Ebolaviruses are highly dangerous pathogens exhibiting extreme virulence in humans and nonhuman primates. The majority of ebolavirus species, most notably Zaire ebolavirus, can cause Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, in humans. EVD is associated with case-fatality rates as high as 90%, and there is currently no specific treatment or licensed vaccine available against EVD. Understanding the molecular biology and pathogenesis of ebolaviruses is important for the development of antiviral therapeutics. Ebolavirus encodes several forms of glycoproteins (GPs), which have some interesting characteristics, including the transcriptional editing coding strategy and extensive O-glycosylation modification, clustered in the mucin-like domain of GP1, full-length GP (GP), and shed GP. In addition to the canonical role of the spike protein, GP, in viral entry, ebolavirus GPs appear to have multiple additional functions, likely contributing to the complex pathogenesis of the virus. Here, we review the roles of ebolavirus GPs in viral pathogenesis.

摘要

埃博拉病毒是高度危险的病原体,对人类和非人类灵长类动物表现出极高的毒力。大多数埃博拉病毒物种,尤其是扎伊尔埃博拉病毒,可导致人类埃博拉病毒病(EVD),以前称为埃博拉出血热。EVD 的病死率高达 90%,目前尚无针对 EVD 的特效治疗方法或已批准的疫苗。了解埃博拉病毒的分子生物学和发病机制对于抗病毒治疗药物的开发很重要。埃博拉病毒编码几种形式的糖蛋白(GPs),这些糖蛋白具有一些有趣的特征,包括转录编辑编码策略和在 GP1 的粘蛋白样结构域、全长 GP(GP)和脱落 GP 中的广泛 O-糖基化修饰。除了 Spike 蛋白 GP 在病毒进入中的典型作用外,埃博拉病毒 GPs 似乎具有多种额外功能,可能有助于病毒的复杂发病机制。在这里,我们综述了埃博拉病毒 GPs 在病毒发病机制中的作用。

相似文献

1
The roles of ebolavirus glycoproteins in viral pathogenesis.埃博拉病毒糖蛋白在病毒发病机制中的作用。
Virol Sin. 2017 Feb;32(1):3-15. doi: 10.1007/s12250-016-3850-1. Epub 2016 Nov 14.
2
Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.三价副流感病毒载体埃博拉病毒疫苗诱导的抗体介导的保护机制。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01845-18. Print 2019 Feb 15.
3
Spontaneous Mutation at Amino Acid 544 of the Ebola Virus Glycoprotein Potentiates Virus Entry and Selection in Tissue Culture.埃博拉病毒糖蛋白第544位氨基酸的自发突变增强了病毒在组织培养中的进入和选择。
J Virol. 2017 Jul 12;91(15). doi: 10.1128/JVI.00392-17. Print 2017 Aug 1.
4
A Naturally Occurring Polymorphism in the Base of Sudan Virus Glycoprotein Decreases Glycoprotein Stability in a Species-Dependent Manner.苏丹病毒糖蛋白碱基中的自然发生多态性以物种依赖的方式降低糖蛋白稳定性。
J Virol. 2021 Aug 25;95(18):e0107321. doi: 10.1128/JVI.01073-21.
5
Release of viral glycoproteins during Ebola virus infection.埃博拉病毒感染期间病毒糖蛋白的释放。
Virology. 1998 May 25;245(1):110-9. doi: 10.1006/viro.1998.9143.
6
Comprehensive functional analysis of N-linked glycans on Ebola virus GP1.埃博拉病毒糖蛋白1(GP1)上N-连接聚糖的综合功能分析
mBio. 2014 Jan 28;5(1):e00862-13. doi: 10.1128/mBio.00862-13.
7
Comparison of N- and O-linked glycosylation patterns of ebolavirus glycoproteins.埃博拉病毒糖蛋白的N-连接和O-连接糖基化模式比较
Virology. 2017 Feb;502:39-47. doi: 10.1016/j.virol.2016.12.010. Epub 2016 Dec 13.
8
Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.基于痘病毒的埃博拉病毒表达 GP 和 VP40 蛋白疫苗候选物的免疫原性和疗效的差异。
J Virol. 2018 May 14;92(11). doi: 10.1128/JVI.00363-18. Print 2018 Jun 1.
9
The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development.埃博拉病毒可溶性糖蛋白在复制、发病机制和对策开发中的作用。
Viruses. 2019 Oct 31;11(11):999. doi: 10.3390/v11110999.
10
Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.丝状病毒糖蛋白保守 B 细胞表位的鉴定和有效性:用于埃博拉和可能的马尔堡病毒病的快速诊断检测。
BMC Infect Dis. 2018 Oct 3;18(1):498. doi: 10.1186/s12879-018-3409-x.

引用本文的文献

1
evolution and emergence are associated with land use change.进化与出现与土地利用变化相关。
Ecol Monogr. 2025 Feb;95(1):e1641. doi: 10.1002/ecm.1641.
2
Ebola Virus GP Activates Endothelial Cells via Host Cytoskeletal Signaling Factors.埃博拉病毒 GP 通过宿主细胞骨架信号因子激活血管内皮细胞。
Viruses. 2022 Jan 13;14(1):142. doi: 10.3390/v14010142.
3
Structural and Functional Aspects of Ebola Virus Proteins.埃博拉病毒蛋白的结构与功能方面
Pathogens. 2021 Oct 15;10(10):1330. doi: 10.3390/pathogens10101330.
4
Investigating the Interaction between Negative Strand RNA Viruses and Their Hosts for Enhanced Vaccine Development and Production.研究负链RNA病毒与其宿主之间的相互作用以促进疫苗开发与生产。
Vaccines (Basel). 2021 Jan 17;9(1):59. doi: 10.3390/vaccines9010059.
5
Development of an antigen detection assay for early point-of-care diagnosis of Zaire ebolavirus.开发一种用于扎伊尔埃博拉病毒早期即时护理点诊断的抗原检测检测方法。
PLoS Negl Trop Dis. 2020 Nov 3;14(11):e0008817. doi: 10.1371/journal.pntd.0008817. eCollection 2020 Nov.
6
Increased Pathogenicity and Virulence of Middle East Respiratory Syndrome Coronavirus Clade B and .中东呼吸综合征冠状病毒 B 型和. 分支的致病性和毒力增强。
J Virol. 2020 Jul 16;94(15). doi: 10.1128/JVI.00861-20.
7
Dendritic Cells/Macrophages-Targeting Feature of Ebola Glycoprotein and its Potential as Immunological Facilitator for Antiviral Vaccine Approach.埃博拉病毒糖蛋白的树突状细胞/巨噬细胞靶向特性及其作为抗病毒疫苗免疫促进剂的潜力
Microorganisms. 2019 Sep 29;7(10):402. doi: 10.3390/microorganisms7100402.
8
A versatile platform technology for recombinant vaccines using non-propagative human parainfluenza virus type 2 vector.一种使用非增殖性人副流感病毒 2 型载体的重组疫苗通用平台技术。
Sci Rep. 2019 Sep 9;9(1):12901. doi: 10.1038/s41598-019-49579-y.
9
Ebola virus VP35 has novel NTPase and helicase-like activities.埃博拉病毒 VP35 具有新型 NTPase 和 helicase 样活性。
Nucleic Acids Res. 2019 Jun 20;47(11):5837-5851. doi: 10.1093/nar/gkz340.
10
Investigation of Outbreak-Specific Nonsynonymous Mutations on Ebolavirus GP in the Context of Known Immune Reactivity.埃博拉病毒 GP 爆发特异性非同义突变的研究及其与已知免疫反应的关系。
J Immunol Res. 2018 Nov 15;2018:1846207. doi: 10.1155/2018/1846207. eCollection 2018.

本文引用的文献

1
A "Trojan horse" bispecific-antibody strategy for broad protection against ebolaviruses.一种用于广泛抵御埃博拉病毒的“特洛伊木马”双特异性抗体策略。
Science. 2016 Oct 21;354(6310):350-354. doi: 10.1126/science.aag3267. Epub 2016 Sep 8.
2
Structures of Ebola virus GP and sGP in complex with therapeutic antibodies.埃博拉病毒 GP 和 sGP 与治疗性抗体复合物的结构。
Nat Microbiol. 2016 Aug 8;1(9):16128. doi: 10.1038/nmicrobiol.2016.128.
3
Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection.尼曼-皮克C1型(NPC1)介导的胆固醇转运与埃博拉病毒感染的结构解析
Cell. 2016 Jun 2;165(6):1467-1478. doi: 10.1016/j.cell.2016.05.022. Epub 2016 May 26.
4
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site.通过糖蛋白受体结合位点内独特暴露的表位对埃博拉病毒和苏丹病毒感染进行抗体治疗。
Cell Rep. 2016 May 17;15(7):1514-1526. doi: 10.1016/j.celrep.2016.04.026. Epub 2016 May 5.
5
Uncovering the mystery of Ebola virus entry: Lock and key.揭开埃博拉病毒进入细胞之谜:锁与钥匙。
Sci China Life Sci. 2016 Apr;59(4):434-5. doi: 10.1007/s11427-016-5033-6. Epub 2016 Mar 11.
6
The Myeloid LSECtin Is a DAP12-Coupled Receptor That Is Crucial for Inflammatory Response Induced by Ebola Virus Glycoprotein.髓系肝窦内皮细胞凝集素是一种与DAP12偶联的受体,对埃博拉病毒糖蛋白诱导的炎症反应至关重要。
PLoS Pathog. 2016 Mar 4;12(3):e1005487. doi: 10.1371/journal.ppat.1005487. eCollection 2016 Mar.
7
Fusion of Enveloped Viruses in Endosomes.包膜病毒在内体中的融合
Traffic. 2016 Jun;17(6):593-614. doi: 10.1111/tra.12389. Epub 2016 Apr 7.
8
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.强效中和抗体对致死性埃博拉病毒感染的保护性单药治疗。
Science. 2016 Mar 18;351(6279):1339-42. doi: 10.1126/science.aad5224. Epub 2016 Feb 25.
9
Structural and molecular basis for Ebola virus neutralization by protective human antibodies.保护性人类抗体中和埃博拉病毒的结构和分子基础。
Science. 2016 Mar 18;351(6279):1343-6. doi: 10.1126/science.aad6117. Epub 2016 Feb 25.
10
Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak.从2014年埃博拉病毒疫情的一名幸存者体内分离出强效中和抗体。
Science. 2016 Mar 4;351(6277):1078-83. doi: 10.1126/science.aad5788. Epub 2016 Feb 18.